UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Form 10-Q
| Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | |
For the Quarterly Period ended March 31, 2012
| Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Commission file number: 000-27866
POWERVERDE, INC.
(Exact name of Registrant as specified in its charter)
| Delaware | 88-0271109 | |
(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) |
420 S. Dixie Highway Suite 4-B
23429 N. 35thCoral Gables, FL33146 Drive, Glendale, Arizona 85310
(Address of principal executive offices)
(305) 666-0024
(Registrant’s telephone number including area code)
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
xS Yes o£ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
| £ | Large accelerated filer | Accelerated filer | ||
| £ | Non-accelerated filer | Smaller reporting company |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
o£ Yes xS No
State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: As of November 14, 2011July 10, 2012 the issuer had 25,624,56528,719,565 shares of common stock outstanding.
Index to Form 10-Q
Page | ||||
| 1 | ||||
| Item 1. | Financial Statements(Unaudited) | 1 | ||
| Condensed Consolidated Balance Sheets | 1 | |||
| 2 | ||||
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 12 | ||||
| 14 | ||||
| 14 | ||||
| 15 | ||||
| 15 | ||||
| 15 | ||||
| 15 | ||||
| 15 | ||||
| 15 | ||||
| 15 | ||||
| 16 | ||||
| SIGNATURES | 17 | |||
| 2011 | 2010 | |||||||
| Assets | ||||||||
| Current Assets: | ||||||||
| Cash and cash equivalents | $ | 234,802 | $ | 15,646 | ||||
| Accounts receivable | 13,491 | 5,350 | ||||||
| Receivable, related party | 10,000 | — | ||||||
| Prepaid insurance | 12,181 | — | ||||||
| Total Current Assets | 270,474 | 20,996 | ||||||
| Property and Equipment | ||||||||
| Property and equipment, net of accumulated depreciation of $18,608 and $13,103, respectively | 17,721 | 12,034 | ||||||
| Total Assets | $ | 288,195 | $ | 33,030 | ||||
| Liabilities and Stockholders’ Equity | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued expenses | $ | 73,680 | $ | 153,891 | ||||
| Total Current Liabilities | 73,680 | 153,891 | ||||||
| Long-Term Liabilities | ||||||||
| Payable to related party | 177,416 | — | ||||||
| Total Long-Term Liabilities | 177,416 | — | ||||||
| Total Liabilities | 251,096 | 153,891 | ||||||
Stockholders’ Equity (Deficiency) | ||||||||
| Preferred stock: 50,000,000 preferred shares authorized, par value $0.0001 per share, no shares issued and outstanding at September 30, 2011 and December 31, 2010 | — | — | ||||||
Common stock: 100,000,000 common shares authorized, par value $0.0001 per share, 30,124,565 common shares issued and 25,624,565 shares outstanding at September 30, 2011 and 28,043,065 common shares issued and outstanding at December 31, 2010 | 3,012 | 2,804 | ||||||
| Additional paid-in capital | 4,679,724 | 2,179,625 | ||||||
| Treasury stock, 4,500,000 shares at cost | (170,758 | ) | — | |||||
| Deficit accumulated in the development stage | (4,474,879 | ) | (2,303,290 | ) | ||||
| Total Stockholders’ Equity (Deficiency) | 37,099 | (120,861 | ) | |||||
| Total Liabilities and Stockholders’ Equity (Deficiency) | $ | 288,195 | $ | 33,030 | ||||
| Item 1. | Financial Statements |
PowerVerde, Inc. and Subsidiary (A Development Stage Company) Condensed Consolidated Balance Sheets March 31, 2012 and December 31, 2011 (Unaudited) |
| 2012 | 2011 | |||||||
| Assets | ||||||||
| Current Assets: | ||||||||
| Cash and cash equivalents | $ | 221,175 | $ | 7,530 | ||||
| Accounts receivable | 14,435 | 18,909 | ||||||
| Prepaid expenses and other current assets | 24,000 | 24,267 | ||||||
| Total Current Assets | 259,610 | 50,706 | ||||||
| Property and Equipment | ||||||||
| Property and equipment, net of accumulated depreciation of $22,434 and $20,521, respectively | 13,896 | 15,809 | ||||||
| Other Assets | ||||||||
| Intellectual Property | 659,440 | — | ||||||
| Goodwill | 2,637,760 | — | ||||||
| Total Other Assets | 3,297,200 | — | ||||||
| Total Assets | $ | 3,570,706 | $ | 66,515 | ||||
| Liabilities and Stockholders’ Equity/(Deficiency) | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued expenses | $ | 325,980 | $ | 179,304 | ||||
| Total Current Liabilities | 325,980 | 179,304 | ||||||
| Long-Term Liabilities | ||||||||
| Payable to related party | 184,632 | 180,988 | ||||||
| Total Long-Term Liabilities | 184,632 | 180,988 | ||||||
| Total Liabilities | 510,612 | 360,292 | ||||||
| Stockholders’ Equity/(Deficiency) | ||||||||
| Common stock: | ||||||||
| 100,000,000 common shares authorized, par value $0.0001 per share,28,384,565 common shares issued and outstanding at March 31, 2012 and 25,624,565 common shares issued and outstanding at December 31, 2011 | 3,288 | 3,012 | ||||||
| Additional paid-in capital | 8,871,802 | 4,730,724 | ||||||
| Treasury stock, 4,500,000 shares at cost | (170,758 | ) | (170,758 | ) | ||||
| Deficit accumulated in the development stage | (5,644,238 | ) | (4,856,755 | ) | ||||
| Total Stockholders’ Equity/(Deficiency) | 3,060,094 | (293,777 | ) | |||||
| Total Liabilities and Stockholders’ Equity/(Deficiency) | $ | 3,570,706 | $ | 66,515 | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
Three months ended September 30, | Nine months ended September 30, | Cumulative from inception through September 30, | ||||||||||||||||||
| 2011 | 2010 | 2011 | 2010 | 2011 | ||||||||||||||||
| Revenue, Net | $ | 143,491 | $ | 9,805 | $ | 174,482 | $ | 28,492 | $ | 265,847 | ||||||||||
| Cost of Goods Sold | 130,000 | — | 136,925 | — | 136,925 | |||||||||||||||
| Gross Profit | 13,491 | 9,805 | 37,557 | 28,492 | 128,922 | |||||||||||||||
| Operating Expenses | ||||||||||||||||||||
| Research and development | 236,730 | 40,706 | 1,430,599 | 115,358 | 1,808,609 | |||||||||||||||
| General and administrative | 299,577 | 32,035 | 795,546 | 147,589 | 2,473,470 | |||||||||||||||
| Total Operating Expenses | 536,307 | 72,741 | 2,226,145 | 262,947 | 4,282,079 | |||||||||||||||
| Loss from Operations | (522,816 | ) | (62,936 | ) | (2,188,588 | ) | (234,455 | ) | (4,153,157 | ) | ||||||||||
| Other Income (Expenses) | ||||||||||||||||||||
| Interest income | — | — | — | — | 2,401 | |||||||||||||||
| Interest expense | (3,502 | ) | — | (6,658 | ) | — | (340,134 | ) | ||||||||||||
| Other income (expense) | — | — | 23,657 | — | 16,011 | |||||||||||||||
| Total Other Income (Expense) | (3,502 | ) | — | 16,999 | — | (321,722 | ) | |||||||||||||
| Loss before Income Taxes | (526,318 | ) | (62,936 | ) | (2,171,589 | ) | (234,455 | ) | (4,474,879 | ) | ||||||||||
| Provision for Income Taxes | — | — | — | — | — | |||||||||||||||
| Net Loss | $ | (526,318 | ) | $ | (62,936 | ) | $ | (2,171,589 | ) | $ | (234,455 | ) | $ | (4,474,879 | ) | |||||
| Net Loss per Share - Basic and Diluted | $ | (0.02 | ) | $ | (0.01 | ) | $ | (0.08 | ) | $ | (0.01 | ) | ||||||||
| Weighted Average Common Shares Outstanding - Basic and Diluted | 25,605,940 | 27,913,644 | 26,579,277 | 27,913,644 | ||||||||||||||||
| Three months ended March 31, | Cumulative from inception through March 31, 2012 | |||||||||||
| 2012 | 2011 | |||||||||||
| Revenue, Net | $ | 14,435 | $ | 10,438 | $ | 299,191 | ||||||
| Cost of Goods Sold | — | — | 136,925 | |||||||||
| Gross Profit | 14,435 | 10,438 | 162,266 | |||||||||
| Operating Expenses | ||||||||||||
| Research and development | 577,036 | 200,086 | 2,584,717 | |||||||||
| General and administrative | 221,239 | 228,519 | 2,892,850 | |||||||||
| Total Operating Expenses | 798,275 | 428,605 | 5,477,567 | |||||||||
| Loss from Operations | (783,840 | ) | (418,167 | ) | (5,315,301 | ) | ||||||
| Other Income (Expenses) | ||||||||||||
| Interest income | — | — | 2,401 | |||||||||
| Interest expense | (3,644 | ) | — | (347,350 | ) | |||||||
| Other | — | 23,657 | 16,011 | |||||||||
| Total Other Income (Expense) | (3,644 | ) | 23,657 | (328,938 | ) | |||||||
| Loss before Income Taxes | (787,484 | ) | (394,510 | ) | (5,644,239 | ) | ||||||
| Provision for Income Taxes | — | — | — | |||||||||
| Net Loss | $ | (787,484 | ) | $ | (394,510 | ) | $ | (5,644,239 | ) | |||
| Net Loss per Share - Basic and Diluted | $ | (0.03 | ) | $ | (0.01 | ) | ||||||
| Weighted Average Common Shares Outstanding - Basic and Diluted | 25,962,587 | 28,644,526 | ||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
Common Shares | Common Stock | Additional Paid in Capital | Treasury Stock | Deficit Accumulated during the Development Stage | Total Stockholders’ Equity (Deficiency) | |||||||||||||||||||
| Balances, December 31, 2010 | 28,043,065 | $ | 2,804 | $ | 2,179,625 | $ | — | $ | (2,303,290 | ) | $ | (120,861 | ) | |||||||||||
| Sale of common stock at $.75 per share, net of stock issuance costs of $150,000 | 2,000,000 | 200 | 1,349,800 | — | 1,350,000 | |||||||||||||||||||
| Stock-based compensation | 415,907 | 415,907 | ||||||||||||||||||||||
| Warrants issued for services | 612,150 | 612,150 | ||||||||||||||||||||||
| Warrants exercised | 81,500 | 8 | 122,242 | 122,250 | ||||||||||||||||||||
| Treasury stock | (4,500,000 | ) | (170,758 | ) | (170,758 | ) | ||||||||||||||||||
| Net loss for the nine months ended September 30, 2011 | — | — | — | (2,171,589 | ) | (2,171,589 | ) | |||||||||||||||||
| Balances, September 30, 2011 | 25,624,565 | $ | 3,012 | $ | 4,679,724 | $ | (170,758 | ) | $ | (4,474,879 | ) | $ | 37,099 | |||||||||||
PowerVerde, Inc. and Subsidiary (A Development Stage Company) Consolidated Statement of Changes in Stockholders’ Equity/(Deficiency ) For the three months ended March 31, 2012 (Unaudited) |
| Common Shares | Common Stock | Additional Paid in Capital | Treasury Stock | Deficit Accumulated during the Development Stage | Total Stockholders’ Equity/(Deficiency) | |||||||||||||||||||
| Balances, December 31, 2011 | 25,624,565 | $ | 3,012 | $ | 4,730,724 | $ | (170,758 | ) | $ | (4,856,755 | ) | $ | (293,777 | ) | ||||||||||
| Sale of common stock at $1.00 per share, net of stock issuance costs of $50,000 | 500,000 | 50 | 449,950 | 450,000 | ||||||||||||||||||||
| Issuance of warrants for settlement with Newton | 262,700 | 262,700 | ||||||||||||||||||||||
| Stock-based compensation | 131,454 | 131,454 | ||||||||||||||||||||||
| Issuance of common stock at $1.37 per share for Cornerstone acquisition | 2,260,000 | 226 | 3,095,974 | 3,096,200 | ||||||||||||||||||||
| Issuance of warrants for Cornerstone acquisition | 201,000 | 201,000 | ||||||||||||||||||||||
| Net loss for the three months ended March 31, 2012 | (787,484 | ) | (787,484 | ) | ||||||||||||||||||||
| Balances, March 31, 2012 | 28,384,565 | $ | 3,288 | $ | 8,871,802 | $ | (170,758 | ) | $ | (5,644,239 | ) | $ | 3,060,094 | |||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 2011 | 2010 | Cumulative from inception through September 30, 2011 | ||||||||||
| Cash Flows from Operating Activities | ||||||||||||
| Net loss | $ | (2,171,589 | ) | $ | (234,455 | ) | $ | (4,474,879 | ) | |||
| Adjustments to reconcile net loss to net cash used by operating activities: | ||||||||||||
| Depreciation, amortization, and impairment charges | 5,505 | 4,251 | 18,608 | |||||||||
| Amortization of discount | 6,658 | — | 336,120 | |||||||||
| Stock based compensation | 415,908 | — | 472,158 | |||||||||
| Warrants issued for services | 612,150 | 612,150 | ||||||||||
| Changes in operating assets and liabilities: | ||||||||||||
| Accounts receivable and other assets | (30,322 | ) | (2,179 | ) | (35,672 | ) | ||||||
| Accounts payable and accrued liabilities | (80,212 | ) | (28,853 | ) | (156,862 | ) | ||||||
| Cash Used in Operating Activities | (1,241,902 | ) | (261,236 | ) | (3,228,377 | ) | ||||||
| Cash Flows From Investing Activities | ||||||||||||
| Purchase of fixed assets | (11,192 | ) | — | (36,328 | ) | |||||||
| Cash acquired in business acquisition | — | — | 872 | |||||||||
| Cash Used in Investing Activities | (11,192 | ) | — | (35,456 | ) | |||||||
| Cash Flows from Financing Activities | ||||||||||||
| Proceeds from issuance of common stock | 1,622,250 | 290,000 | 3,652,250 | |||||||||
| Proceeds from notes payable | — | — | 300,000 | |||||||||
| Payment of line of credit | — | — | (50,000 | ) | ||||||||
| Payment of note payable | — | — | (90,217 | ) | ||||||||
| Payment of stock issuance costs | (150,000 | ) | (29,000 | ) | (313,398 | ) | ||||||
| Cash Provided by Financing Activities | 1,472,250 | 261,000 | 3,498,635 | |||||||||
| Net Increase (Decrease) in Cash | 219,156 | (236 | ) | 234,802 | ||||||||
| Cash and Cash Equivalents, at Beginning of Period | 15,646 | 20,457 | — | |||||||||
| Cash and Cash Equivalents, at End of Period | $ | 234,802 | $ | 20,221 | $ | 234,802 | ||||||
| Supplemental Disclosure of Cash Flow Information | ||||||||||||
| Cash paid during the period for interest | $ | — | $ | — | $ | 24,221 | ||||||
| Cash paid during the period for income taxes | $ | — | $ | — | $ | — | ||||||
| Supplemental Schedule of Non-Cash Financing Activities | ||||||||||||
| Common stock issued for convertible debt | $ | — | $ | — | $ | 189,261 | ||||||
| Common stock issued for services | $ | — | $ | — | $ | 56,250 | ||||||
| Purchase of treasury stock with long-term related party payable | $ | 170,758 | $ | — | $ | 170,758 | ||||||
| Warrants issued in connection with debt | $ | — | $ | — | $ | 299,984 | ||||||
| Common stock issued in connection with debt forgiveness and services rendered | $ | — | $ | — | $ | 250,000 | ||||||
| 2012 | 2011 | Cumulative from inception through March 31, 2012 | ||||||||||
| Cash Flows from Operating Activities | ||||||||||||
| Net loss | $ | (787,484 | ) | $ | (394,510 | ) | $ | (5,644,239 | ) | |||
| Adjustments to reconcile net loss to net cash used by operating activities: | ||||||||||||
| Depreciation, amortization, and impairment charges | 1,913 | 1,680 | 22,434 | |||||||||
| Amortization of discount | 3,644 | — | 343,336 | |||||||||
| Stock based compensation | 131,454 | 131,454 | 654,603 | |||||||||
| Warrants issued for services | — | — | 612,150 | |||||||||
| Warrants issued for settlement | 262,700 | — | 262,700 | |||||||||
| Changes in operating assets and liabilities: | ||||||||||||
| Accounts receivable and other assets | 4,741 | (5,088 | ) | (38,435 | ) | |||||||
| Inventory | — | (140,105 | ) | |||||||||
| Deposit on build to suit unit | — | 30,000 | ||||||||||
| Accounts payable and accrued liabilities | 146,677 | (89,100 | ) | 95,449 | ||||||||
| Cash Provided by (Used in) Operating Activities | (236,355 | ) | (465,669 | ) | (3,692,002 | ) | ||||||
| Cash Flows From Investing Activities | ||||||||||||
| Purchase of fixed assets | — | (11,193 | ) | (36,330 | ) | |||||||
| Cash acquired in business acquisition | — | — | 872 | |||||||||
| Cash Used in Investing Activities | — | (11,193 | ) | (35,458 | ) | |||||||
| Cash Flows from Financing Activities | ||||||||||||
| Proceeds from issuance of common stock and warrants | 500,000 | 1,000,000 | 4,152,250 | |||||||||
| Proceeds from notes payable | — | — | 300,000 | |||||||||
| Payment of line of credit | — | — | (50,000 | ) | ||||||||
| Payment of note payable | — | — | (90,217 | ) | ||||||||
| Payment of stock issuance costs | (50,000 | ) | (100,000 | ) | (363,398 | ) | ||||||
| Cash Provided by Financing Activities | 450,000 | 900,000 | 3,948,635 | |||||||||
| Net Increase (Decrease) in Cash | 213,645 | 423,138 | 221,175 | |||||||||
| Cash, at Beginning of Period | 7,530 | 15,646 | $ | — | ||||||||
| Cash, at End of Period | $ | 221,175 | $ | 438,784 | $ | 221,175 | ||||||
| Supplemental Disclosure of Cash Flow Information | ||||||||||||
| Cash paid during the period for interest | ||||||||||||
| Cash paid during the period for income taxes | $ | — | $ | — | $ | 24,221 | ||||||
| $ | — | $ | — | $ | — | |||||||
| Supplemental Schedule of Non-Cash Financing Activities | ||||||||||||
| Common stock issued for convertible debt | — | — | $ | 189,261 | ||||||||
| Common stock issued for services | $ | — | $ | — | $ | 56,250 | ||||||
| Common stock issued for acquisition of Cornerstone Conservation Group, LLC | $ | 3,096,200 | $ | — | $ | 3,096,200 | ||||||
| Warrants issued in connection with acquisition of Cornerstone Conservation Group, LLC | $ | 201,000 | $ | — | $ | 201,000 | ||||||
| Purchase of treasury stock with long-term related party payable | $ | — | $ | — | $ | 170,758 | ||||||
| Warrants issued in connection with debt | $ | — | $ | — | $ | 299,984 | ||||||
| Common stock issued in connection with debt forgiveness and services rendered | $ | — | $ | — | $ | 250,000 | ||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
PowerVerde, Inc. and Subsidiary
March 31, 2012
Note 1 – Condensed Consolidated Financial Statements
The accompanying unaudited condensed consolidated financial statements prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the annual reportAnnual Report of PowerVerde, Inc. (“PowerVerde,” “we,” “us,” “our”“our,” or the “Company”) as of and for the year ended December 31, 2010.2011. The results of operations for the ninethree months ended September 30, 2011,March 31, 2012, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of PowerVerde, Inc., formerly known as Vyrex Corporation (the “Company”"Company"), and PowerVerde Systems, Inc., formerly known as PowerVerde, Inc., its wholly-owned subsidiary. Intercompany balances and transactions have been eliminated in consolidation.
Note 2 – Going Concern
The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has had recurring operating losses and negative cash flows from operations. Those factors, as well as uncertainty in securing additional funds for continued operations, create an uncertainty about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Note 3 – Summary of Significant Accounting Policies
Development Stage Company
The Company records reserves for inventory shrinkageis a development stage company as defined in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 915, “Development Stage Entities.” The Company is devoting substantially all of its present efforts to establish a new business and obsolescence, whennone of its planned principal operations have commenced. All losses accumulated since inception have been considered necessary. At September 30, 2011as part of the Company had no inventory.
Accounts Receivable
Accounts receivable consist of balances due from sales and royalties. The Company monitors accounts receivable and provides allowances when considered necessary. At September 30, 2011,March 31, 2012, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided.
Revenue Recognition
Sales revenues and associated cost of sales are recognized when title of the goods sold pass to the buyer, when shipped and when accounts receivable are determined to be reasonably collectable. Certain sales agreements also require installation and training by PowerVerde once goods are received and accepted by the customer. The Company does not consider these agreements multiple elements arrangements as defined by ASC 605-25 Revenue Recognition, as the Company does not offer installation or training as services separate from the sale of its products at this time. Therefore a “best estimate of selling price” or individual pricing in accordance with ASC 605-25 is undeterminable. The Company defers all revenues and costs of sales until the agreement is 100% complete.
Licensing and royalty revenue from royalty agreements is recognized in accordance with the terms of the specific agreement.
Property and Equipment
Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Expenditures for major betterments and additions are capitalized, while replacement, maintenance and repairs, which do not extend the lives of the respective assets, are expensed as incurred.
Intellectual Property and Goodwill
The Company reviews intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. In the event of impairment, the Company would discount the future cash flows using its then estimated incremental borrowing rate to estimate the amount of the impairment.
Goodwill is evaluated for impairment at least annually or more frequently if events or changes in circumstances indicate that the carrying amount may not be recoverable. The impairment analysis involves a two step process. Step one involves the comparison of the fair value of the reporting unit to which goodwill relates (the Company’s enterprise value) to the carrying value of the reporting unit. If the fair value exceeds the carrying value, there is no impairment. If the carrying value exceeds the fair value of the reporting unit, the Company determines the implied fair value of goodwill and records an impairment charge for any excess of the carrying value of goodwill over its implied fair value.
Stock-based Compensation
The Company accounts for share-based compensation in accordance with ASC Topic 718Share-Based Payments. The Company has used the Black-Scholes option pricing model to estimate the fair value of stock options on the date of grant.
Common Stock Purchase Warrants
The Company accounts for common stock purchase warrants in accordance with ASC Topic 815-40,815- 40, Derivatives and Hedging – Contracts in Entity’s Own Equity (“ASC 815-40”). Based on the provisions of ASC 815-40,815- 40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (includingincluding a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).
Accounting for Uncertainty in Income Taxes
The Company applies the accounting standard regarding “Accounting for Uncertain Tax Positions” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements, and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The standard also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.
Based on our evaluation, we have concluded that there are no significant uncertain tax positions requiring recognition in our consolidated financial statements. Our evaluation was performed for the tax years ended December 31, 2007, 2008, 2009, 2010 and 2010,2011, the tax years which remain subject to examination by major tax jurisdictions as of September 30, 2011.
We may from time to time be assessed interest or penalties by major tax jurisdictions, although any such assessments historically have been minimal and immaterial to our financial results. In the event we have received an assessment for interest and/or penalties, it has been classified in the consolidated financial statements as selling, general and administrative expense.
Research and Development Costs
The Company’s research and development costs are expensed in the period in which they are incurred.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.
Financial Instruments and Fair Values
The fair value of a financial instrument represents the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale. Fair value estimates are made at a specific point in time, based upon relevant market information about the financial instrument.
The carrying amount of cash and cash equivalents, trade receivables and other assets approximates fair value due to the short-term maturities of these instruments.
The fair values of all other financial instruments, including debt, approximate their book values as the instruments are short-term in nature or contain market rates of interest.
Note 4 – Recent Accounting Pronouncements
In December 2011, the Company adopted Financial Accounting Standards Board (“FASB”) Accounting Standard Update (“ASU”) 2009-13, “Revenue Recognition (Topic 605): Multiple-Deliverable Revenue Arrangements – a consensus of the FASB Emerging Issues Task Force.” Thisissued ASU amended the criteria2011-11 “Disclosures about offsetting Assets and Liabilities” requiring additional disclosure about offsetting and related arrangements. ASU 2011-11 is effective retrospectively for when to evaluate individual delivered items in a multiple deliverable arrangement and how to allocate consideration received.periods beginning on or after January 1, 2013. The adoption of this guidance didASU 2011-11 will not have a material impact on the Company’s consolidatedfuture financial statements.
Note 5 – Acquisition
On March 30, 2012, the FASB issued ASU 2011-04, “Fair Value Measurement (Topic 820): AmendmentsCompany purchased 100% of the membership interests of Cornerstone Conservation Group LLC (“Cornerstone”) pursuant to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS,” which provides common requirements for measuring fair value and disclosing information about fair value measurements in accordance with U.S. GAAP and International Financial Reporting Standards (“IFRS”a Membership Interest Purchase Agreement (the “Agreement”). This ASUCornerstone’s main asset is effectiveits proprietary Combined Cooling, Heating and Power (“CCHP”) technology, which utilizes waste heat from commercial and residential heating, ventilation air conditioning and refrigeration (“HVACR”) systems. Cornerstone also has substantial experience and technology relating to geothermal or ground source heat pumps. The Company also moved its operations to a 5,000 square foot facility owned by one of the sellers in Scottsdale, Arizona. The Company has been using the facility rent-free on a short-term basis but expects to negotiate a lease on fair market terms.
In consideration for fiscal years beginning on or after December 15, 2011. The adoptionthe 100% membership interests in Cornerstone, the Company issued 2,260,000 shares of this standard is not expected to have a material impact on the Company’s consolidated financial statements
| (i) | 100,000 shares at an exercise price of $2.00 per share, exercisable beginning January 1, 2012, through December 31, 2016; | |
| (ii) | 100,000 shares at an exercise price of $3.00 per share, exercisable beginning July 1, 2012, through June 30, 2017; and | |
| (iii) | 100,000 shares at an exercise price of $4.00 per share, exercisable beginning January 1, 2013, through December 31, 2017. |
The estimated fair value of the total warrants issued in connection with the acquisition of Cornerstone was $201,000 which was calculated using the Black-Scholes option valuation method with the following assumptions: a reporting unit is less than its carrying amount, it need not perform the two-step impairment test. Early adoption is permitted.risk free interest rate of 1.04 percent, an estimated volatility of 79.1 percent and no dividend yield. The adoptiontotal present value of all consideration expected to be paid as part of this standardagreement was $3,297,200.
The following summarizes the fair values of the assets acquired:
| Intangible asset – Research and Development | $ | 659,440 | ||
| Goodwill | 2,637,760 | |||
| Total assets acquired | 3,297,200 | |||
| Aggregate purchase price | $ | 3,297,200 |
The assets acquired were recorded at preliminary estimates of fair values determined by management, based on information currently available and on current assumptions as to future operations, and are subject to change upon the completion of acquisition accounting, including the finalization of asset valuations.
The following unaudited pro forma financial information presents the combined results of operations of the Company and Cornerstone as if the acquisition had occurred as of January 1, 2012. The pro forma information is not expectednecessarily indicative of what the financial position or results of operations actually would have been had the acquisition been completed as of January 1, 2012. In addition, the unaudited pro forma financial information is not indicative of, nor does it purport to have a material impact onproject, the Company’s consolidatedfuture financial statements.
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENTS OF OPERATIONS INFORMATION
| For the Three Months Ended March 31 | ||||||||
| 2012 | 2011 | |||||||
| Revenue | $ | 29,043 | $ | 49,193 | ||||
| Net loss attributable to common shareholders of the Company | $ | (877,443 | ) | $ | (462,440 | ) | ||
| Basic and diluted net loss per common share attributable to common shareholders of PowerVerde | $ | (0.03 | ) | $ | (0.02 | ) | ||
Note 56 – Property and Equipment
A summary of property and equipment at September 30, 2011March 31, 2012 and December 31, 20102011 is as follows:
| September 30, 2011 | December 31, 2010 | Estimated Useful Lives (in years) | ||||||||
| Equipment | $ | 25,426 | $ | 22,339 | 5 | |||||
| Computer equipment (hardware) | 6,974 | 2,798 | 3-5 | |||||||
| Software | 3,929 | — | 3 | |||||||
| 36,329 | 25,137 | |||||||||
| Less: Accumulated depreciation | (18,608 | ) | (13,103 | ) | ||||||
| $ | 17,721 | $ | 12,034 | |||||||
| March 31, 2012 | December 31, 2011 | Estimated Useful Lives (in years) | ||||||||||
| Equipment | $ | 25,426 | $ | 25,426 | 5 | |||||||
| Computer equipment (hardware) | 6,974 | 6,974 | 3-5 | |||||||||
| Software | 3,929 | 3,929 | 3 | |||||||||
| 36,329 | 36,329 | |||||||||||
| Less: Accumulated depreciation | (22,434 | ) | (20,521 | ) | ||||||||
| $ | 13,896 | $ | 15,809 | |||||||||
The amounts charged to operations for depreciation for the ninethree months ended September 30,March 31, 2012 and 2011 were $1,913 and 2010 were $5,505 and $4,251,$1,680, respectively.
Note 67 – Stockholders’ Equity
Warrants
In 2008, the Company issued warrants to purchase 250,000 and 50,000 unregistered shares of the Company’s common stock at exercise prices of $1.50 and $2.30 per share, respectively. Of these warrants 50,000 were still outstanding as of September 30, 2011. The warrants expireexpired on various dates through November 2011. At September 30, 2011,168,500March 31, 2012, 218,500 of these warrants had expired and 81,500 were exercised.
During March through December 2010, the Company issued warrants to purchase 439,999 unregistered shares of the Company’s common stock at an exercise price of $0.75 per share in association with stock subscription agreements. These warrants expire on various dates through December 2013. As of November 14, 2011,March 31, 2012, none of these warrants were exercised or had expired.
During January through JuneDecember 2011, the Company issued warrants to purchase 2,000,000 unregistered shares of the Company’s common stock at an exercise price of $0.75 per share in association with stock subscription agreements. These warrants expire on various dates through June 2014. As of November14, 2011,March 31, 2012, none of these warrants were exercised or had expired.
The Company issued warrants on June 3, 2011 to various persons, including affiliates of the Company, for services provided to the Company. These warrants covered the purchase of 1,855,000 unregistered shares of the Company’s stock at an exercise price of $1.05 per share with a five-year term. These share-based payments have been accounted for in accordance with ASC 815-40 using the Black Scholes warrant pricing model to determine the fair value of each warrant.
On February 3, 2012, The Company issued warrants to purchase 500,000 unregistered shares of the Company’s common stock at an exercise price of $1.00 per share with a five-year term for settlement of certain disputed amounts (See Note 9). These share-based payments have been accounted for in accordance with ASC 815-40 using the Black-Scholes warrant pricing model to determine the fair value of each warrant.
In connection with the acquisition of Cornerstone (See Note 5), on March 30, 2012, the Company issued warrants to purchase 300,000 unregistered shares of common stock at exercise prices ranging from $2.00 to $4.00 per share. These warrants expire at various dates through December 2017.
Expenses related to warrants issued for servicesin conjunction with settlement of certain disputes for the ninethree months ended September 30,March 31, 2012 and 2011 and 2010 were $612,150$262,700 and $0, respectively.
A summary of warrants issued, exercised and expired during the ninethree months ended September 30, 2011March 31, 2012 is as follows:
| Shares | Weighted Average Exercise Price | |||||||
| Balance at December 31, 2010 | 739,999 | 1.11 | ||||||
| Issued | 3,855,000 | .89 | ||||||
| Exercised | (81,500) | 1.50 | ||||||
| Expired | (168,500 | ) | 1.50 | |||||
| Balance at September 30, 2011 | 4,344,999 | 0.90 | ||||||
| Shares | Weighted Average Exercise Price | ||||||||
| Balance at December 31, 2011 | 4,294,999 | 0.88 | |||||||
| Issued | 800,000 | 1.75 | |||||||
| Balance at March 31, 2012 | 5,094,999 | 1.02 | |||||||
The weighted average grant date fair value of warrants issued during the ninethree month period September 30, 2011ended March 31, 2012 amounted to $1.02$0.52 to $0.77 per warrant. The fair value of each warrant granted as compensation for services was determined using the Black-Scholes warrant pricing model and the following assumptions:
| Risk | ||||
| Expected | 5.0 years | |||
| Annualized volatility | ||||
Expected dividends | — | |||
The expected term of warrants granted is based on the contractual terms of the agreement and represents the period of time that warrants granted are expected to be outstanding.
The warrant shares referred to above are unregistered shares of the Company’s stock and are restricted from trading as defined under Rule 144 of the United States Securities Act of 1933.
Private Placement of Common Stock
In the first nine months of 2011,February 2012, the Company raised $1,500,000gross proceeds of $500,000 through the private placement of 2,000,000500,000 shares of its common stock to accredited investors at $0.75$1.00 per share. Each investor received a three-year warrant to purchase unregistered stock at $0.75 per share for a number of shares of common stock equalThe private placement was undertaken pursuant to the number of shares purchased by the investor in this offering. On January 31, 2011,Agreement between the Company entered into a Binding Letter of Intent for European Distribution (the “BLOI”) withand Newton, Investments BV, a Dutch corporation based in Leeuwarden, Netherlands (“Newton”), as disclosed in Note 8,9, below. The $1,500,000 referred to above includes a $250,000 investment purchased by a Newton affiliate in conjunction with the Newton BLOI.
Treasury Shares
On April 7, 2011, 4,500,000 shares of the Company’s stock were surrendered to Treasury in exchange for a $200,000 interest-free note payable in April 2013. See Note 8 - Commitments.
Preferred Shares
The Company has 50,000,000 shares of authorized, $0.0001 par value preferred stock. At September 30, 2011,March 31, 2012, no shares had been issued.
Note 78 – Stock Options
Stock option activity for the nine monthsquarter ended September 30, 2011,March 31, 2012, is summarized as follows:
| Shares | Weighted Average Exercise Price | Weighted Average Remaining Contractual Life (Years) | ||||||||||
| Options outstanding at December 31, 2010 | — | $ | — | |||||||||
| Granted | 1,950,000 | $ | 0.91 | |||||||||
| Expired or forfeited | — | — | ||||||||||
| Options outstanding at September 30, 2011 | 1,950,000 | $ | 0.91 | 10.00 | ||||||||
| Options exercisable at September 30, 2011 | 412,500 | $ | 0.85 | 10.00 | ||||||||
| Options vested or expected to vest at September 30, 2011 | 487,500 | $ | 0.91 | 10.00 | ||||||||
| Shares | Weighted Average Exercise Price | Weighted Average Remaining Contractual Life (Years) | |||||||||||
| Options outstanding at December 31, 2011 | 1,750,000 | $ | 0.91 | 10.00 | |||||||||
| Granted | — | — | — | ||||||||||
| Options outstanding at March 31, 2012 | 1,750,000 | $ | 0.91 | 9.8 | |||||||||
Total stock option compensation for the ninethree months ended September 30,March 31, 2012 and 2011 and 2010 was $415,907 and $0, respectively.$131,454 for each of the periods. Remaining stock option compensation of $721,909$335,454 will be recognized ratably over 18 months fromthrough the grant date.
Note 89 – Commitments and Contingencies
On September 29, 2011, the Company entered into a license agreement (the “License Agreement”) with Newton. This is the definitive agreement contemplated by the BLOI, described above. Pursuant to the License Agreement, Newton will, for a period of 10 years, hold the exclusive manufacturing and distribution rights for the Systems in the 27 countries which are currently members of the European Union, subject to Newton’s achieving minimum sales of at least 100 Systems per year beginning in the second year of the License Agreement, payment of a royalty equal to 20% of the gross sales price of each System sold, and other terms and conditions set forth in the License Agreement.
In the first quarter of 2012, the Company entered intoraised $500,000 exclusively from accredited European investors (including
$275,000 from a Binding LetterNewton affiliate) pursuant to a private placement of Intent for Acquisition (the “Letter500,000 shares of Intent”)common stock at a price of $1.00 per share. There was no warrant issued pursuant to this round; however, simultaneously Newton affiliates received three-year warrants to purchase 500,000 shares at $1.00 per share in connection with Bryce Johnson (“Johnson”), Paul Kelly (“Kelly”)the settlement of certain claims by and Vince Hils (“Hils”), each individuals (collectively, the “Sellers”). Pursuant to the Letter of Intent,between the Company and Sellers agreed to enter into a definitive agreement within 60 days, pursuant to which the Sellers shall sell, assign and transfer toNewton.
Note 10. Subsequent Events.
In April 2012, the Company 100%purchased 100,000 shares of common stock from a company owned by its Director and cofounder Fred Barker at a price of $.25 per share. Of the membership interests$25,000 purchase price, $14,000 was paid in Cornerstone Conservation Group LLC, an Arizona limited liability company (“Cornerstone”), free2011 and clearthe balance in April 2012. The shares will be held as treasury stock from the date of any and all liens, claims and encumbrances (the “Interests”). As a result,closing.
In May 2012, the Company will indirectly own all of Cornerstone’s intellectual property described on Exhibit “A” attached to the Letter of Intent. In consideration for the Interests, the Company will issue (i) 2,260,000purchased 450,000 shares of its common stock from Mr. Barker at a price of $0.20 per share. Of the $90,000 purchase price, $10,000 was paid at closing and the balance is payable $10,000 per month through January 2013. The shares will be held as treasury stock from the date of closing.
In the second quarter of 2012, the Company raised gross proceeds of $335,000 through the private placement of 335,000 unregistered shares of common stock to the Sellers and their affiliates; and (ii) fully vested three–year warrantsaccredited investors at $1.00 per share. Each investor received a three-year warrant to purchase an aggregate of 300,000 shares of the Company’s common stock consisting of 50,000 shares to Johnson at an exercise price of $2.00 per share, exercisable beginning January 1, 2012, 50,000 shares to Kelly at an exercise price of $2.00 per share, exercisable beginning January 1, 2012, 50,000 shares to Johnson at an exercise price of $3.00 per share exercisable beginning July 1, 2012, 50,000for a number of shares to Kelly at an exercise price of $3.00 per share, exercisable beginning July 1, 2012, 50,000 shares to Johnson at an exercise price of $4.00 per share, exercisable beginning January 1, 2013, and 50,000 shares to Kelly at an exercise price of $4.00 per share, exercisable beginning January 1, 2013.
Item 2.Management’s Management's Discussion and Analysis of Financial Condition and Results of Operations
Forward Looking Statements
Readers are cautioned that the statements in this Report that are not descriptions of historical facts may be forward-looking statements that are subject to risks and uncertainties. This Report contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements are based on the beliefs of our management, as well as on assumptions made by and information currently available to us as of the date of this Report. When used in this Report, the words “plan,” “will,” “may,” “anticipate,” “believe,” “estimate,” “expect,” “intend,” “project” and similar expressions are intended to identify such forward-looking statements. Although we believe these statements are reasonable, actual actions, operations and results could differ materially from those indicated by such forward-looking statements as a result of the risk factors included in our 20102011 Annual Report, or other factors. We must caution, however, that this list of factors may not be exhaustive and that these or other factors, many of which are outside of our control, could have a material adverse effect on us and our ability to achieve our objectives. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above.
The following discussion and analysis should be read in conjunction with the financial statements and notes thereto appearing elsewhere herein.
Critical Accounting Policies
The condensed consolidated financial statements of PowerVerde, Inc. are prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of these condensed consolidated financial statements requires our management to make estimates and assumptions about future events that effect the amounts reported in the financial statements and related notes. Future events and their effects cannot be determined with absolute certainty. Therefore, the determination of estimates requires the exercise of judgment. We believe the following critical accounting policies affect its more significant judgments and estimates used in the preparation of financial statements.
Revenue Recognition
Sales revenues and associated cost of sales are recognized when title of the goods sold pass to the buyer, when shipped, and when accounts receivable are determined to be reasonably collectable. Certain sales agreements also require installation and training by PowerVerde once goods are received and accepted by the customer. The Company does not consider these agreements multiple elements arrangements as defined by ASC 605-25Revenue Recognition, as the Company does not offer installation or training as services separate from the sale of its products, at this time, and therefore a “best estimate of selling price” or individual pricing in accordance with ASC 605-25 is undeterminable. The Company defers all revenues and costs of sales until the agreement is 100% complete.
Licensing and royalty revenue from royalty agreements is recognized in accordance with the terms of the specific agreement.
Stock-based Compensation
We account for share-based compensation in accordance with ASC Topic 718Share-Based Payments. We have used the Black-Scholes option pricing model to estimate the fair value of stock options on the date of grant.
Common Stock Purchase Warrants
The Company accounts for common stock purchase warrants in accordance with ASC Topic 815-40,Derivatives and Hedging – Contracts in Entity’s Own Equity (“ASC 815-40”). Based on the provisions of ASC 815-40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).
Overview
From January 1991 until October 2005, the Company devoted substantially all of its efforts and resources to research and development related to its unsuccessful Biotech Business, in particular the study of biological oxidation and antioxidation directed to the development of potential therapeutic products for the treatment of various diseases and conditions. In the most recent years, the Company’s research focused mainly on targeted antioxidant therapeutics and nutraceuticals. The Company is a development stage company, has generated only limited revenue from product sales and has relied primarily on equity financing, licensing revenues, and various debt instruments for its working capital. The Company has been unprofitable since its inception.
Following the cessation of material Biotech Business operations in October 2005, the Company turned its primary focus to seeking an appropriate merger partner for its public shell. This resulted in the February 2008 merger with Vyrex (the “Merger”). In March 2009, we assigned our Biotech IP to an investor in exchange for his agreement to pay all future expenses relating to the Biotech IP and to pay us 20% of any net proceeds received from sale and/or licensing of the Biotech IP. We do not expect this arrangement to generate material revenues.
Since the Merger, we have focused on the development, testing and commercialization of our electric power systems, in particular, their applicability to thermal and natural gas pipeline operations. Our business is subject to significant risks, including the risks inherent in our research and development efforts, uncertainties associated with obtaining and enforcing patents and intense competition.
Except as specifically noted to the contrary, the following discussion relates only to PowerVerde since, as a result of the Merger, the only historical financial statements presented for the Company in periods following the Merger are those of the operating entity, PowerVerde.
Results of Operations
Three Months Ended September 30, 2011March 31, 2012 as Compared to Three Months Ended September 30, 2010
Since inception, we have focused on the development, testing and commercialization of our clean energy electric power generation systems. We had $143,491 ofno material revenues in the first quarter of 2012 and 2011 consisting of $130,000 from our current business— just $14,435 and $13,491$10,438 in Biotech IP licensing fees, compared to $9,805 in Biotech IP licensing fees in 2010. Meanwhile, we had substantial expenses due to our ongoing research and development and commercialization activities, as well as substantial administrative expenses, including the cost of warrants and options issued and expenses associated with our status as a public company. Our net loss during the third quarter of 2011 and 2010 was $526,318 and $62,936, respectively. This substantially increased loss in 2011 was due primarily to the increase of payroll expenses for engineers, professional fees, advertising costs, travel expenses and the value of stock-based compensation vested in the three-month period..
Liquidity and Capital Resources
We have financed our operations since inception through the sale of debt and equity securities. As of September 30, 2011,March 31, 2012, we had a working capital deficit of $196,794,$66,370 compared to a working capital deficit of $132,895$128,598 at December 31, 2010.
During the first nine monthsquarter of 2011,2012, we raised gross proceeds of $1,500,000$500,000 through the private placement of 2,000,000500,000 unregistered shares of our common stock to accredited investors at $0.75$1.00 per share. Each investor received a three-year warrant to purchase stock at $0.75 per share for a number of shares of common stock equal to the number of shares purchased by the investor in this offering. The $1,500,000 included a $250,000 investment by a Newton affiliate in conjunction with the Newton BLOI, as referred to in Note 8 - Commitments of the footnotes to the Unaudited Condensed Consolidated Financial Statements. We paid a 10% commission on the gross proceeds of this offering to our placement agent, Martinez-Ayme Securities. We also
In the second quarter of 2012, we raised $122,250 from warrants that were exercised during July and August 2011.
We believe that our current level of working capital will be sufficient to sustain our current operations through at least approximately the end of 2011.next two months. However, we continue to seek more funding from private equity investors, as well as governmental sources, as we will need to raise substantial additional capital in order to finance our plan of operations. There can be no assurance that we will be able to raise the necessary funds. If we do not raise the necessary funds, we will be forced to cease operations.
Not applicable.
Evaluation of Disclosure Controls and Procedures
The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and President, evaluated the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective.
Changes in Internal Control Over Financial Reporting
There were no significant changes in internal control over financial reporting during the ninethree months ended September 30, 2011March 31, 2012 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
None.
There are no material changes to the risk factors set forth in Part I, Item 1A, “Risk Factors,” of the 20102011 Annual Report. Please refer to that section for disclosure regarding the risks and uncertainties related to our business.
In the first quarter of 2012, we raised $500,000 exclusively from accredited European investors (including $275,000 from a Newton affiliate) pursuant to a private placement of $500,000 shares of common stock at a price of $1.00 per share. There was no warrant issued pursuant to this round; however, simultaneously Newton affiliates received three-year warrants to purchase 500,000 shares at $1.00 per share in connection with the settlement of certain claims by and between the Company and Newton.
In the second quarter of 2012, we raised gross proceeds of $335,000 through the private placement of 335,000 unregistered shares of our common stock to accredited investors at $1.00 per share. Each investor received a three-year warrant to purchase shares of our common stock at $3.00 per share for a number of shares equal to the number of shares purchased by the investor in this offering. We paid a 10% commission on the gross proceeds of this offering to our placement agent, Martinez-Ayme Securities.
In March 2012, in connection with our acquisition of 100% of the membership interests of Cornerstone Conservation Group LLC, we issued 2,260,000 shares of common stock and fully vested three-year warrants to purchase 300,000 shares of our common stock at prices ranging from $2.00-$4.00 per share. See Note 5 of Notes to Unaudited Condensed Consolidated Financial Statements.
The foregoing issuances were made pursuant to the private offering exemption from registration provided in Section 4(2) of the Securities Act of 1933, as amended. All proceeds of these sales were used for working capital.
Not applicable.
In April 2012, we entered into a license agreement (the “License Agreement”) with Newton. This is the definitive agreement contemplated by the BLOI, described above. Pursuant to the License Agreement, Newton will, for a period of 10 years, hold the exclusive manufacturing and distribution rights for the Systems in the 27 countries which are currently members of the European Union, subject to Newton’s achieving minimum sales of at least 100 Systems per year beginning in the second year of the License Agreement, payment of a royalty equal to 20% of the gross sales price of each System sold, and other terms and conditions set forth in the License Agreement.
In May 2012, we purchased 450,000 shares of our common stock consisting of 50,000 shares to Johnsonfrom Mr. Barker at an exercisea price of $2.00$0.20 per share, exercisable beginningshare. Of the $90,000 purchase price, $10,000 was paid at closing and the balance is payable $10,000 per month through January 1, 2012, 50,0002013. The shares to Kelly at an exercise price of $2.00 per share, exercisable beginning January 1, 2012, 50,000 shares to Johnson at an exercise price of $3.00 per share, exercisable beginning July 1, 2012, 50,000 shares to Kelly at an exercise price of $3.00 per share, exercisable beginning July 1, 2012, 50,000 shares to Johnson at an exercise price of $4.00 per share, exercisable beginning January 1, 2013, and 50,000 shares to Kelly at an exercise price of $4.00 per share, exercisable beginning January 1, 2013.
(a) Exhibits
| 31.1 | Certification of Principal Executive Officer and Principal Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 31.2 | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 32.1 | Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
| 32.2 | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
In accordance with Section 13(a) or 15(d) of the Exchange Act, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| POWERVERDE, INC. | |||
| Dated: | July 11, 2012 | By: | /s/ Richard H. Davis |
| Richard H. Davis | |||
| Chief Executive Officer | |||
| Dated: | July 11, 2012 | By: | /s/ John L. Hofmann |
| John L. Hofmann | |||
| Chief Financial Officer | |||
Exhibit Index
Exhibit No. | Description | |
| 31.1 | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 31.2 | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 32.1 | Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 32.2 | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |